Login to Your Account



Search

Search results

Pharma: Clinic roundup

CSL Behring Ltd. , of King of Prussia, Pa., said the first patient has been enrolled in the pivotal pediatric phase III study to evaluate the efficacy, safety and pharmacokinetics of its investigational recombinant factor VIII single chain (rVIII-Sin ...

BioWorld Today - Staff - 2014-05-05 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Teva Pharmaceutical Industries Ltd ., of Jerusalem, reported positive results from a pivotal phase III study of hydrocodone bitartrate extended-release tablets designed with Teva's proprietary technology providing potential abuse-deterrent properties ...

BioWorld Today - Staff - 2014-05-01 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Upsher-Smith Laboratories Inc. , of Maple Grove, Minn., reported phase I data for USL261 (investigational intranasal midazolam) in patients with epilepsy were presented at the 66th Annual American Academy of Neurology (AAN) meeting in Philadelphia. ...

BioWorld Today - Staff - 2014-04-30 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Sanofi Pasteur, the vaccines division of Sanofi SA , of Paris, said the first of two pivotal phase III efficacy studies with its dengue vaccine candidate has achieved its primary clinical endpoint. The study showed a reduction of 56 percent of dengue ...

BioWorld Today - Staff - 2014-04-29 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Teva Pharmaceutical Industries Ltd. , of Jerusalem, said it enrolled the first patient in the Pride-HD study, a phase II trial designed to evaluate the impact of pridopidine, an oral, small molecule, on motor impairment in patients with Huntington's ...

BioWorld Today - Staff - 2014-04-25 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Eisai Co. Ltd. , of Tokyo, reported that Zonegran (zonisamide) was well tolerated and efficacious when used as an adjunctive treatment for partial epilepsy, with or without secondary generalization, in children between the ages of 6 and 17 for at lea ...

BioWorld Today - Staff - 2014-04-23 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Ferring Pharmaceuticals SA , of Saint Prex, Switzerland, reported data from the EXPEDITE study at the First European Congress on Intrapartum Care in Amsterdam, the Netherlands, which demonstrated that use of a controlled-release misoprostol v ...

BioWorld Today - Staff - 2013-05-29 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Abbvie Inc. , of North Chicago, initiated a global phase III trial evaluating the safety and efficacy of veliparib (ABT-888) in patients with previously untreated locally advanced or metastatic squamous non-small-cell lung cancer (NSCLC). (B ...

BioWorld Today - Staff - 2014-04-16 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Dompe Group , of Milan, said it started a phase Ib/II study to assess the safety and potential efficacy of recombinant human nerve growth factor (rhNGF) eye drops in two doses vs. placebo. (BioWorld-Today-2014-04-04) ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Bayer HealthCare Pharmaceuticals Inc. , of Whippany, N.J., began enrollment in a trial studying Xofigo (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mil ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments